Japan / The Latest Therapeutic Applications in Induced Pluripotent Stem Cell (iPSC) Technology
Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park looks at how a technology developed in Japan…
Cell & Gene Therapy
Sweden / Taking the Lead in Precision Medicine?
Anders Blanck of Lif, the trade association for the research-based Swedish pharmaceutical industry, outlines the steps already being put in place for Sweden to become a leading country in the…
Cell & Gene Therapy / CRISPR-Cas9 Nobel Prize Pioneers in Profile
On 7 October 2020, the 2020 Nobel Prize in Chemistry was jointly awarded to Emmanuelle Charpentier and Jennifer A.…
China / Edigene CEO on Gene Editing Biotech’s Ambitious Expansion Plans
Following a recent capital injection of USD 67 million, Chinese biotech EdiGene is set to advance its pipeline in…
In Conversation
Jon Amund Kyte – Head, Department of Experimental Cancer Treatment, OUH Comprehensive Cancer Center, Oslo University Hospital, Norway
Photo: Sofia Linden / Oslo Cancer Cluster Oncologist Jon Amund Kyte shares some of the groundbreaking immunotherapy research that he and his team is conducting at Oslo University Hospital. Kyte also explores how Norway can better develop its clinical footprint and what his hopes for the future of experimental cancer treatment in the country are. [Norway] should stop thinking…
Top 5 RNA-Based Biopharma Companies
Below we present a list of the top 5 public biopharma companies that focus on developing RNA-based therapies. RNA…
Cell & Gene Therapy / CRISPR-Cas9 Nobel Prize Pioneers in Profile
On 7 October 2020, the 2020 Nobel Prize in Chemistry was jointly awarded to Emmanuelle Charpentier and Jennifer A.…
Cell & Gene Therapy / Command? Consent? Collaborate!
Novartis Oncology’s Emanuele Ostuni (lead author) and Karin Blumer draw on their experience commercialising CAR-T…
Sweden / Taking the Lead in Precision Medicine?
Anders Blanck of Lif, the trade association for the research-based Swedish pharmaceutical industry, outlines the…
Japan / The Latest Therapeutic Applications in Induced Pluripotent Stem Cell (iPSC) Technology
Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park looks at how a technology developed in Japan…
Cell & Gene Therapy / CRISPR-Cas9 Nobel Prize Pioneers in Profile
On 7 October 2020, the 2020 Nobel Prize in Chemistry was jointly awarded to Emmanuelle Charpentier and Jennifer A.…
USA / Paying for Cell & Gene Therapy: Is the Future Already Here?
Certara’s Ulrich Neumann looks at the challenges that payment models for cell and gene therapy (CGT) have faced,…
Cell & Gene Therapy Launches / Zolgensma® in Belgium: Lessons Learned
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy…
Opinion / Can We Afford to Pay for Future Cures?
Pharmaceutical innovation is racing ahead of the US health system’s ability to adjust payment models, but…
Tackling the Talent Gap in Cell & Gene Therapy
Rare diseases and cell and gene therapy executive recruitment specialist Steve Smith outlines six key strategies…
The Cell & Gene Therapy Market: Coming into Its Own
David H. Crean, managing director for Objective Capital Partners, highlights the latest trends in the cell and…
Cell & Gene Therapy / Command? Consent? Collaborate!
Novartis Oncology’s Emanuele Ostuni (lead author) and Karin Blumer draw on their experience commercialising CAR-T…
US Medicare Vows to Increase Payments for Cell & Gene Therapy
Medicare, a national health insurance program in the United States covering Americans aged 65 and older as well as…
Cell & Gene Therapy / Finding the Funding in France
France – one of the most influential countries in the development of gene therapy– still stands as a global…